PT1194153E - LIQUID PHARMACEUTICAL FORMULATIONS WITH MASKED TASTE - Google Patents

LIQUID PHARMACEUTICAL FORMULATIONS WITH MASKED TASTE

Info

Publication number: PT1194153E
Authority: PT; Portugal
Prior art keywords: pharmaceutical formulations; liquid pharmaceutical; masked taste; masked; taste
Prior art date: 1999-07-09

Application number

PT00944752T

Other languages

Portuguese (pt)

Inventor

Danny Yu

Edward Roche

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-09

Filing date

2000-06-21

Publication date

2004-09-30

2000-06-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-09-30 Publication of PT1194153E publication Critical patent/PT1194153E/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT00944752T 1999-07-09 2000-06-21 LIQUID PHARMACEUTICAL FORMULATIONS WITH MASKED TASTE PT1194153E (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US14301999P	1999-07-09	1999-07-09

Publications (1)

Publication Number	Publication Date
PT1194153E true PT1194153E (en)	2004-09-30

Family

ID=22502238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT00944752T PT1194153E (en)	1999-07-09	2000-06-21	LIQUID PHARMACEUTICAL FORMULATIONS WITH MASKED TASTE

Country Status (25)

Country	Link
US (2)	US6482823B1 (en)
EP (1)	EP1194153B1 (en)
JP (1)	JP2003504335A (en)
KR (2)	KR100675809B1 (en)
CN (1)	CN1174740C (en)
AR (1)	AR027179A1 (en)
AT (1)	ATE265852T1 (en)
AU (1)	AU773555B2 (en)
BR (1)	BR0012326A (en)
CA (1)	CA2377916C (en)
DE (1)	DE60010464T2 (en)
DK (1)	DK1194153T3 (en)
EE (1)	EE05147B1 (en)
ES (1)	ES2219360T3 (en)
HR (1)	HRP20020119A2 (en)
HU (1)	HUP0201765A3 (en)
IL (2)	IL147510A0 (en)
MX (1)	MXPA02000331A (en)
NO (1)	NO20020086L (en)
NZ (1)	NZ516486A (en)
PL (1)	PL197812B1 (en)
PT (1)	PT1194153E (en)
SK (1)	SK322002A3 (en)
TR (1)	TR200200710T2 (en)
WO (1)	WO2001003698A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60128215T2 (en) *	2000-04-20	2008-01-10	Novartis Ag	COATING COMPOSITION FOR TASTE MASKING
BR0207930A (en) *	2001-03-05	2004-03-02	Ortho Mcneil Pharm Inc	Masked flavor liquid pharmaceutical compositions
US20040013737A1 (en) *	2002-07-19	2004-01-22	Philippe Becourt	Taste masked oral composition of telithromycin
WO2004013047A2 (en) *	2002-08-02	2004-02-12	Eggs In The Pipeline, Llc.	System for adding consumable enhancing additives to drinking water
US20080020096A1 (en) *	2003-08-01	2008-01-24	Blum Bradley J	System for Adding Consumable Enhancing Additives to Drinking Water
KR101059057B1 (en) *	2003-09-12	2011-08-24	류가쿠산 가부시키가이샤	Granular Jelly Drink Can Block Bitter Taste
US7713482B2 (en)	2003-12-18	2010-05-11	The Clorox Company	Control scheme for enhanced filtered water systems
US7378015B2 (en) *	2003-12-18	2008-05-27	The Clorox Company	Filtered water enhancements
US8236349B2 (en)	2004-04-12	2012-08-07	Bend Research Inc.	Taste-masked drugs in rupturing multiparticulates
JP2006232789A (en) *	2005-02-28	2006-09-07	Sawai Pharmaceutical Co Ltd	Composition for oral formulation and process thereof
US20060216355A1 (en) *	2005-03-28	2006-09-28	Donald Spector	Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents
US7874489B2 (en) *	2005-06-20	2011-01-25	Authentiform Technologies, Llc	Product authentication
EP1907988B1 (en) *	2005-06-20	2013-11-06	AuthentiForm Technologies, L.L.C.	Systems and methods for product authentication
US8247018B2 (en) *	2005-06-20	2012-08-21	Authentiform Technologies, Llc	Methods for quality control
US7973022B2 (en) *	2006-02-17	2011-07-05	Idexx Laboratories, Inc.	Fluoroquinolone carboxylic acid salt compositions
US20070197469A1 (en) *	2006-02-17	2007-08-23	Murthy Yerramilli V	Fluoroquinolone carboxylic acid salt compositions
EP2091519B1 (en)	2006-11-30	2015-06-24	Bend Research, Inc	Multiparticulates of spray-coated drug and polymer on a meltable core
WO2009136398A2 (en) *	2008-05-06	2009-11-12	Dexcel Ltd	Stable benzimidazole formulation
CN101618217B (en) *	2009-07-27	2011-12-28	洛阳君山制药有限公司	Method for coating gastralgia tablets
KR101636958B1 (en) *	2009-09-11	2016-07-06	주식회사 대웅제약	Ursodesoxycholic Acid-Synthetic Hydrotalcite-Eudragit Nanohybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the Same
CN102753196A (en) *	2009-12-10	2012-10-24	莫诺索尔克斯有限公司	Ph sensitive compounds in taste masking within oral thin film strips
RU2589697C2 (en) *	2009-12-18	2016-07-10	Экзодос Лайф Сайенсиз Лимитед Партнершип	Methods of producing a stable liquid drugs and compositions thereof
EP2915098A4 (en)	2012-10-30	2016-07-06	Certirx Corp	Product, image, or document authentication, verification, and item identification
WO2014144661A1 (en)	2013-03-15	2014-09-18	Aprecia Pharmaceuticals Compny	Rapidly dispersible dosage form of topiramate
ES2761265T3 (en)	2013-03-15	2020-05-19	Aprecia Pharmaceuticals LLC	Rapidly dispersible oxcarbazepine dosage form
KR102414503B1 (en)	2016-03-17	2022-06-29	티오제네시스 테라퓨틱스, 인크.	Compositions for Controlled Release of Cysteamine and Systemic Treatment of Cysteamine Sensitive Disorders
KR102088315B1 (en)	2017-10-23	2020-03-13	주식회사 웅진릴리에뜨	Method for preventing off flavors in enteric capsule and enteric capsule therefor
BR112020014457A8 (en) *	2018-01-22	2022-07-26	Currahee Holding Company Inc	PERFORATED CAPSULES
EP3883546A1 (en)	2018-11-21	2021-09-29	Rosemont Pharmaceuticals Ltd	Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN117503701A (en) *	2023-12-08	2024-02-06	斯坦德医药研发(江苏)有限公司	Levofloxacin oral suspension preparation and preparation method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS62226926A (en)	1986-03-27	1987-10-05	Teisan Seiyaku Kk	Long acting complex granule
US5065094A (en)	1990-08-07	1991-11-12	Seagate Technology, Inc.	Two terminal magnetoresistive sensor having DC blocking capacitor
FR2665635A1 (en)	1990-08-10	1992-02-14	Merck Sharp & Dohme	FLUID PHARMACEUTICAL COMPOSITION BASED ON METAL COMPLEX AND PROCESS FOR PREPARING THE SAME.
CA2068402C (en)	1991-06-14	1998-09-22	Michael R. Hoy	Taste mask coatings for preparation of chewable pharmaceutical tablets
US5599556A (en)	1991-12-31	1997-02-04	Abbott Laboratories	Prolamine coatings for taste masking
DE4200821A1 (en)	1992-01-15	1993-07-22	Bayer Ag	TASTE-MASKED PHARMACEUTICAL AGENTS
FR2694751B1 (en)	1992-08-14	1994-11-25	Bouchara Sa	New sulfonamide derivatives, processes for their preparation and compositions containing them.
US5614222A (en) *	1994-10-25	1997-03-25	Kaplan; Milton R.	Stable aqueous drug suspensions and methods for preparation thereof

2000
- 2000-06-21 MX MXPA02000331A patent/MXPA02000331A/en active IP Right Grant
- 2000-06-21 AT AT00944752T patent/ATE265852T1/en not_active IP Right Cessation
- 2000-06-21 HR HR20020119A patent/HRP20020119A2/en not_active Application Discontinuation
- 2000-06-21 CN CNB008101442A patent/CN1174740C/en not_active Expired - Fee Related
- 2000-06-21 PT PT00944752T patent/PT1194153E/en unknown
- 2000-06-21 HU HU0201765A patent/HUP0201765A3/en unknown
- 2000-06-21 US US09/598,157 patent/US6482823B1/en not_active Expired - Lifetime
- 2000-06-21 WO PCT/US2000/016969 patent/WO2001003698A1/en not_active Ceased
- 2000-06-21 CA CA002377916A patent/CA2377916C/en not_active Expired - Fee Related
- 2000-06-21 DE DE60010464T patent/DE60010464T2/en not_active Expired - Fee Related
- 2000-06-21 PL PL352761A patent/PL197812B1/en unknown
- 2000-06-21 TR TR2002/00710T patent/TR200200710T2/en unknown
- 2000-06-21 IL IL14751000A patent/IL147510A0/en active IP Right Grant
- 2000-06-21 JP JP2001508978A patent/JP2003504335A/en active Pending
- 2000-06-21 BR BR0012326-9A patent/BR0012326A/en not_active Application Discontinuation
- 2000-06-21 AU AU58802/00A patent/AU773555B2/en not_active Ceased
- 2000-06-21 ES ES00944752T patent/ES2219360T3/en not_active Expired - Lifetime
- 2000-06-21 KR KR1020027000287A patent/KR100675809B1/en not_active Expired - Fee Related
- 2000-06-21 SK SK32-2002A patent/SK322002A3/en unknown
- 2000-06-21 EE EEP200200012A patent/EE05147B1/en not_active IP Right Cessation
- 2000-06-21 EP EP00944752A patent/EP1194153B1/en not_active Expired - Lifetime
- 2000-06-21 NZ NZ516486A patent/NZ516486A/en unknown
- 2000-06-21 KR KR1020027000319A patent/KR20020029668A/en not_active Ceased
- 2000-06-21 DK DK00944752T patent/DK1194153T3/en active
- 2000-07-07 AR ARP000103477A patent/AR027179A1/en unknown
2002
- 2002-01-08 IL IL147510A patent/IL147510A/en not_active IP Right Cessation
- 2002-01-08 NO NO20020086A patent/NO20020086L/en not_active Application Discontinuation
- 2002-09-24 US US10/253,683 patent/US6586012B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60010464D1 (en)	2004-06-09
AU5880200A (en)	2001-01-30
AR027179A1 (en)	2003-03-19
PL352761A1 (en)	2003-09-08
CA2377916C (en)	2008-03-11
US6482823B1 (en)	2002-11-19
KR100675809B1 (en)	2007-02-01
IL147510A0 (en)	2002-08-14
DE60010464T2 (en)	2005-05-12
HRP20020119A2 (en)	2003-12-31
US20030064107A1 (en)	2003-04-03
SK322002A3 (en)	2003-02-04
EE200200012A (en)	2003-02-17
HUP0201765A2 (en)	2002-11-28
DK1194153T3 (en)	2004-08-02
EP1194153A1 (en)	2002-04-10
BR0012326A (en)	2002-03-12
ES2219360T3 (en)	2004-12-01
IL147510A (en)	2007-06-03
WO2001003698A1 (en)	2001-01-18
NO20020086D0 (en)	2002-01-08
CA2377916A1 (en)	2001-01-18
HUP0201765A3 (en)	2004-05-28
MXPA02000331A (en)	2002-06-21
EP1194153B1 (en)	2004-05-06
JP2003504335A (en)	2003-02-04
NZ516486A (en)	2003-10-31
KR20020029668A (en)	2002-04-19
EE05147B1 (en)	2009-04-15
AU773555B2 (en)	2004-05-27
PL197812B1 (en)	2008-04-30
KR20020031382A (en)	2002-05-01
CN1360504A (en)	2002-07-24
US6586012B2 (en)	2003-07-01
TR200200710T2 (en)	2002-08-21
NO20020086L (en)	2002-03-05
CN1174740C (en)	2004-11-10
ATE265852T1 (en)	2004-05-15

Publication	Publication Date	Title
PT1194153E (en)	2004-09-30	LIQUID PHARMACEUTICAL FORMULATIONS WITH MASKED TASTE
ATE411068T1 (en)	2008-10-15	MEDICINE DISPENSER
DE122010000011I1 (en)	2010-07-08	Liquid gonadotropin-containing drugs
NO20022970L (en)	2002-06-20	Hydrogel-driven drug dosage form
DE60016271D1 (en)	2004-12-30	drug delivery
DK1204410T3 (en)	2012-10-29	PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE COMPONENTS
NO20015175D0 (en)	2001-10-23	Pharmaceutical composition
PT1221918E (en)	2005-06-30	ADMINISTRATION OF SUB-TENON DRUGS
ITTO20010008A0 (en)	2001-01-10	PHARMACEUTICAL FORMULATION
EE200200038A (en)	2003-04-15	Preserved pharmaceutical preparations
FIU20000164U0 (en)	2000-04-11	New pharmaceutical formulation
NO20020531D0 (en)	2002-02-01	Beta-carbolin drug products
DK1183026T3 (en)	2006-11-06	Improved pharmaceutical formulations comprising ritonavir
PT1173434E (en)	2003-12-31	NEW PHARMACEUTICAL PRODUCT
NO20022606D0 (en)	2002-05-31	Pharmaceutical combinations
PT1228039E (en)	2004-09-30	N-GUANIDINOALQUILAMIDES ITS PREPARATION ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
ID30032A (en)	2001-11-01	PHARMACEUTICAL FORMULATION
PT1227817E (en)	2004-11-30	AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
FI4488U1 (en)	2000-07-20	Pharmaceutical composition
AR025867A1 (en)	2002-12-18	PHARMACEUTICAL PORTASDORA FORMULATION
EE200100697A (en)	2003-02-17	Pharmaceutical complex
NO20004816D0 (en)	2000-09-26	New pharmaceutical formulation
DE69904021D1 (en)	2003-01-02	LIQUID PHARMACEUTICAL PREPARATION CONTAINING ZOTEPIN
SI1194153T1 (en)	2004-10-31	Taste masked pharmaceutical liquid formulations
SE9803952D0 (en)	1998-11-18	Pharmaceutical formulation